Greenberg Traurig advised ONO Pharmaceuticals while Goodwin Procter acted for Deciphera.
May 02, 2024 at 02:12 PM
1 minute read
Asia Editor
Greenberg Traurig and Goodwin Procter are advising on the $2.4 billion sale of American cancer drugmaker Deciphera to Japanese company ONO Pharmaceutical.
Under the terms of the agreement, ONO will acquire all outstanding shares of Deciphera, a 2003-founded biopharmaceutical company focused on developing cancer drugs, for $25.60 per share in cash.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
Black Owl Recruiting is looking for a number of qualified applicants to fill positions for a highly reputable client. Recent experience work...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
